<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2021.114012</article-id><article-id pub-id-type="publisher-id">JDM-112941</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Diabetic Foot: Epidemiological and Clinical Aspects in the Department of Medicine and Endocrinology of the Hospital of Mali, Mali
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nanko</surname><given-names>Doumbia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Danfaga</surname><given-names>Bakary</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nouhoum</surname><given-names>Ouologuem</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Drissa</surname><given-names>Sangare</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adams</surname><given-names>Alexis Diarra</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Magara</surname><given-names>Samaké</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sekou</surname><given-names>Mamadou Cisse</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamady</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahamadou</surname><given-names>Saliou</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bakary</surname><given-names>Dembele</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yacouba</surname><given-names>L. Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Kone</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Modibo</surname><given-names>Mariko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bah</surname><given-names>Traore</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Massama</surname><given-names>Konate</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djenebou</surname><given-names>Traore</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djeneba</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kaya</surname><given-names>Assetou Soucko</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assa</surname><given-names>Traore</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib></contrib-group><aff id="aff7"><addr-line>Internal Medicine Department of the CHU du Point G, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Nephrology Unit of the Fousseyni DAOU Hospital in Kayes, Kayes, Mali</addr-line></aff><aff id="aff5"><addr-line>Department of Medicine and Medical Specialty of the Fousseyni Daou Hospital, Kayes, Mali</addr-line></aff><aff id="aff6"><addr-line>Health and Social Affairs Department of the National Police, Bamako, Mali</addr-line></aff><aff id="aff8"><addr-line>Faculty of Medicine of Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine of the Mali Hospital, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>National Center for Scientific and Technological Research (CNRST), Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>Kati Reference Center, Kati, Mali</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>09</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>159</fpage><lpage>170</lpage><history><date date-type="received"><day>27,</day>	<month>September</month>	<year>2021</year></date><date date-type="rev-recd"><day>31,</day>	<month>October</month>	<year>2021</year>	</date><date date-type="accepted"><day>3,</day>	<month>November</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Diabetes is a heterogeneous group of metabolic diseases characterized by chronic hyperglycemia resulting from a defect in the secretion and/or action of insulin, diagnosed by the observation of high levels of glucose in the blood, responsible in the long term for vascular and nervous complications. The diabetic foot is the set of pathological manifestations affecting the foot in relation to the diabetic disease. Approximately 5% of diabetics present a chronic lesion of the foot. 
  Objective: To describe the epidemiological and clinical aspects of the diabetic foot in the medicine/endocrinology department of the Mali hospital. 
  Methodology: This was a retrospective descriptive study from November 2011 to December 2015. It focused on diabetic patients hospitalized in the department with a foot wound and aged 14 years and over. Results: The study involved 94 patients out of 828 hospitalized, a prevalence of 11.35%. Our series included 36 (38.3%) men and 58 (61.7%) women, 
  <em>i.e.</em> a sex ratio of 0.61%. The mean age was 42.66 years with extremes of 14 and 81 years. Type 2 diabetes was present in 95% of the patients with a duration of evolution of more than 5 years in 60.6% of the cases. The mechanism of occurrence of the wounds was minor trauma in 54 cases (57.4%). Self-medication was the primary treatment in 70 patients (74.5%). More than 50% of the patients wore unsuitable footwear. Clinical and para-clinical examinations revealed isolated neuropathy in 37 cases (39.4%), necrotic wound in 37 cases (39.19%), poor glycemic control: HbA1c &gt; 7% (98.9%), absence of osteitis (57.4%), normal Doppler ultrasound 45 cases (45.7%), stenosing arteriopathy 11 cases (22.3%), non-stenosing 3 cases (20.2%), germs present 56 cases (59.6%) including 21 cases (22.4%) of 
  <em>Staphylococcus aureus</em>. 
  Conclusion: Diabetes and diabetic foot constitute a real public health problem. They are responsible for dreadful and sometimes disabling complications. Its management is multidisciplinary and requires significant financial resources.
 
</p></abstract><kwd-group><kwd>Diabetic Foot</kwd><kwd> Epidemiology</kwd><kwd> Clinic</kwd><kwd> Bamako</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Diabetes is a heterogeneous group of metabolic diseases characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or action. It is diagnosed by the observation of high blood glucose levels. In the long term, it is responsible for vascular and nervous complications.</p><p>According to the International Diabetes Federation [<xref ref-type="bibr" rid="scirp.112941-ref1">1</xref>]:</p><p>1) In 2015, the number of diabetics in the world was estimated at 415 million including 14.2 million in Africa;</p><p>2) This figure will rise to 642 million people worldwide, including 34.2 million in Africa in 2040.</p><p>The prevalence of diabetes varies according to the type of diabetes and the country. In the top 10 countries with high prevalence of type 1 diabetes in children (0 - 14 years), Nigeria ranks 9th and 1st in Africa with 14,400 cases. The prevalence of diabetes is 1.8% nationwide [<xref ref-type="bibr" rid="scirp.112941-ref1">1</xref>].</p><p>Diabetic foot: is the set of pathological manifestations affecting the foot as a consequence of diabetic disease. About 5% of diabetics present a chronic lesion of the foot [<xref ref-type="bibr" rid="scirp.112941-ref2">2</xref>]. It is estimated that 30% to 70% of non-traumatic amputations of the lower limbs concern diabetics [<xref ref-type="bibr" rid="scirp.112941-ref3">3</xref>]. Diabetic foot injuries have a functional and psychological impact.</p><p>We initiated this work in view of the following observations:</p><p>1) In Mali, in the hospital setting there are few studies on the frequency of diabetic foot (16.37% in 2013 at the Mali Hospital) [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>].</p><p>2) The increase in the number of cases in the service.</p><p>Objectives: To describe the epidemio-clinical aspects of diabetic foot in the medicine/endocrinology department of Mali Hospital.</p></sec><sec id="s2"><title>2. Methodology</title><p>We conducted a retrospective, descriptive study from November 1, 2011 to December 31, 2015 in the medicine/endocrinology department of Mali Hospital in Bamako, which is the reference in the management of diabetic feet in Mali, ranked 3rd reference. All diabetic patients arriving in the department with a foot infection, aged 14 years and older were included. All non-diabetic patients under 14 years of age were not included. Information was collected from the patients files through a questionnaire including socio-demographic data, history of diabetes, type of diabetes, mechanism of occurrence of the wound, associated lesions.</p><p>The data were entered and/or analyzed using software on Epi-Info version 7.0.9, Word 2007, SPSS version 20.0, Excel 2007. Strict anonymity of the patients was respected.</p></sec><sec id="s3"><title>3. Results</title><p>During the period we identified 94 cases of diabetic foot out of a total of 828 diabetic hospitalized patients, a prevalence of 11.35%.</p><p>The age group 41 - 60 years represented more than half of the study population (61.3%) with a mean age of 42.66 years (see <xref ref-type="table" rid="table1">Table 1</xref>), the extremes being 14 and 81 years. The female sex was the most represented with a sex ratio of 0.61. The majority of our patients (51) did not attend school (54.3%). Housewives represented half of the study population (50%) (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). The weight was abnormal in 88 patients (93.8%) (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). A family history of diabetes was found in 37 patients (39.4%) (see <xref ref-type="table" rid="table2">Table 2</xref>). Type 2 diabetes was most represented in 89 patients (95%). Family history of diabetes 37 cases (39.4%), Family history of hypertension 6 cases (6.4%), Family history of diabetes + hypertension 8 cases (8.5%). Trauma was the most frequent mechanism of occurrence in 54 cases (57.4%) (see <xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Self-medication was observed in the first place in 70 patients (74.5%), patients wore unsuitable shoes in 60 cases (63.8%). Diabetes had been present for more than 5 years in 57 patients (60.6%), neuropathy was found in 37 cases (39.4%), arteriopathy in 4 cases (4.3%) and mixed foot in 4 cases (4.3%) (Cf. <xref ref-type="table" rid="table4">Table 4</xref>), gangrene in 38 cases (40.4%) (Cf. <xref ref-type="table" rid="table5">Table 5</xref>), glycemic imbalance in 81 patients (86.2%), presence of osteitis in 40 patients (42.6%), abnormal doppler ultrasound in 40 patients (42.5%) (Cf. <xref ref-type="fig" rid="fig3">Figure 3</xref>). The wound was graded: stage A Grade 0 in 5 cases (4.7%), stage D Grade 3: 32 cases with 29.8% (Cf. <xref ref-type="table" rid="table6">Table 6</xref>) (Picture 1).</p></sec><sec id="s4"><title>4. Discussion</title><p>The study included 94 cases out of a total of 828 hospitalized diabetic patients, i.e. a hospital frequency of 11.35%. Djim, F. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] and Koffi, D. [<xref ref-type="bibr" rid="scirp.112941-ref5">5</xref>] reported respectively 16.37% and 15.29%. The age group 40 - 60 years was the most represented in the study population, i.e. 61.3%, Djim, F.C. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] et al. found 59.6%. The mean age was 42.66 years, other African studies: Sani, R. et al. [<xref ref-type="bibr" rid="scirp.112941-ref6">6</xref>], Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>], Gu&#232;ye, D.D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref8">8</xref>], Sano, D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref9">9</xref>], Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref10">10</xref>] found respectively 53 years, 54 years, 57 years, 58.9 years, 60.74 years.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Age distribution</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >AGE (year)</th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >14 - 20</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1</td></tr><tr><td align="center" valign="middle" >21 - 40</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >41 - 60</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >61.3</td></tr><tr><td align="center" valign="middle" >61 and more</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >30.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution by family history</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Background Family</th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >39.4</td></tr><tr><td align="center" valign="middle" >HTA</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6.4</td></tr><tr><td align="center" valign="middle" >HTA + Diabetes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.5</td></tr><tr><td align="center" valign="middle" >no previous history</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >12.8</td></tr><tr><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >33.0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution according to the mode of occurrence of the wound</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mechanism of wound occurrence</th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Minimal trauma</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >57.4</td></tr><tr><td align="center" valign="middle" >Burns</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >16.0</td></tr><tr><td align="center" valign="middle" >Intertrigo or mycosis</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.5</td></tr><tr><td align="center" valign="middle" >Friction</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.5</td></tr><tr><td align="center" valign="middle" >Undetermined</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution by foot component</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Foot components</th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Neuropathy</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >39.4</td></tr><tr><td align="center" valign="middle" >Arteriopathy</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.3</td></tr><tr><td align="center" valign="middle" >Neuropathy and Arteriopathy</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.3</td></tr><tr><td align="center" valign="middle" >Pure infection</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.3</td></tr><tr><td align="center" valign="middle" >Neuropathy + Arteriopathy + Infection</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >23.4</td></tr><tr><td align="center" valign="middle" >No neuropathy</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >24.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution by type of lesion</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of lesions</th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Superficial</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >28.7</td></tr><tr><td align="center" valign="middle" >Necrosis without gangrene</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >30.9</td></tr><tr><td align="center" valign="middle" >Wet Gangrene</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >20.2</td></tr><tr><td align="center" valign="middle" >Dry Gangrene</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.5</td></tr><tr><td align="center" valign="middle" >Mixed Gangrene</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >11.7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution by TU classification</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Grade</th><th align="center" valign="middle"  colspan="4"  >Wound stage</th></tr></thead><tr><td align="center" valign="middle" >Stage A</td><td align="center" valign="middle" >Stage B</td><td align="center" valign="middle" >Stage C</td><td align="center" valign="middle" >Stage D</td></tr><tr><td align="center" valign="middle" >Grade 0</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Grade 1</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Grade 2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Grade 3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >28</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >32</td></tr></tbody></table></table-wrap><disp-formula id="scirp.112941-formula2"><graphic  xlink:href="//html.scirp.org/file/4-4300658x5.png?20211102164530792"  xlink:type="simple"/></disp-formula><p>Picture 1. Plantar perforation disease.</p><p>Women were in the majority with a sex ratio of 0.61, Samak&#233;, D. [<xref ref-type="bibr" rid="scirp.112941-ref11">11</xref>] and Djim, F.C. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] et al. found a sex ratio of 0.59 and 0.47 respectively.</p><p>The sex ratio was 0.61. This same female predominance was observed by some authors such as Sano, D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref9">9</xref>] 0.43, Gu&#232;ye, D.D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref8">8</xref>] 0.6, on the other hand, others had found a male predominance: Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>] 1.8, Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref10">10</xref>] 1.38, Sani, R. et al. [<xref ref-type="bibr" rid="scirp.112941-ref6">6</xref>] 2.46.</p><p>The majority of our patients were not in school with 54.3%. This result is close to those of Traor&#233;, D.Y. [<xref ref-type="bibr" rid="scirp.112941-ref12">12</xref>] 55.5% and Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>] 47%.</p><p>The level of schooling is very important for patients in terms of therapeutic education, helping them to understand the tools. Housewives represented (50%) of the patients. Djim, F.C. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] et al. found 53.3%. Weight was abnormal in 93.8%, this was found by Djim, F.C. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] et al. 42.5%.</p><p>Family history of diabetes was found in 39% of patients. Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] and Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>] found 44.6%, 47% respectively. This explains by the high prevalence of T2DM in our study.</p><p>Type 2 diabetics accounted for 94.7%. Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] had found 91.5% against 8.5% of type 1. This predominance of type 2 over type 1 is classic, 90% of diabetics have type 2 diabetes Eko&#233;, J. et al. [<xref ref-type="bibr" rid="scirp.112941-ref13">13</xref>]. Complications of type 2 diabetes are the most frequent because patients are very often poorly balanced. We found the notion of a family history of arterial hypertension 6.4%, and Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] found 2.1%. Diabetes associated with familial hypertension was found in 8.5%, Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] found 10.6%. Minimal trauma was the mode of discovery in 54 cases (57.4%). Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] found 61.7%. Self-medication was observed in 74.5%. Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>], Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>] reported 51.1% and 58% respectively. Unsuitable shoes were used by 63.8% of our patients. This risk factor for the occurrence of diabetic foot was found by Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>], Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref10">10</xref>] respectively 31.9%; 1.43%. Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref10">10</xref>].</p><p>Diabetes had been present for more than 5 years in 60.6% of patients, Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] had found 46.8% of patients with diabetes.</p><p>Neuropathy was found in 37 cases (39.4%), arteriopathy in 4 cases (4.3%) and mixed foot in 4 cases (4.3%). Elsewhere some authors have found: Sano, D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref9">9</xref>] neuropathy (75.5%), arteriopathy (31.5%), Gu&#232;ye, D.D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref8">8</xref>] 22.6% mixed component.</p><p>Neuropathy and arteriopathy are considered to be favourable factors for diabetic foot disease and are closely linked to glycaemic imbalance. The combination of arteriopathy and infection increases the risk of foot amputation by 50 to 100%, regardless of the type of lesion.</p><p>At admission, 40.4% of patients had gangrene. Sani, R. et al. [<xref ref-type="bibr" rid="scirp.112941-ref6">6</xref>], Djim, F. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>], Gu&#232;ye, D.D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref8">8</xref>], Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref10">10</xref>] respectively found 40%, 44.6%, 54.60%, 61.29%.</p><p>Examination of the feet is an essential element during each consultation and allows early detection of lesions and feet at risk and to reduce the severity.</p><p>The majority of patients were unbalanced 86.2%. Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] 80.9%. This imbalance favors the rapid onset of chronic complications.</p><p>The foot X-ray showed the presence of osteitis in 42.6% of cases. Nghario, L. et al. [<xref ref-type="bibr" rid="scirp.112941-ref7">7</xref>], Djibril, A.M. et al. [<xref ref-type="bibr" rid="scirp.112941-ref11">11</xref>], Koffi, D. [<xref ref-type="bibr" rid="scirp.112941-ref5">5</xref>] and Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] found respectively 14.5%, 21.42%, 39% and 45.7%. In our series, 42.5% of the patients had arteriopathy of the lower limbs, 22.3% of which were stenosing. Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] 48.6% of lower limb arteriopathy and 20% obliterating, Sano, D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref9">9</xref>] 31.5%. Doppler ultrasonography of the lower limbs is a crucial examination which, when coupled with clinical examination, often allows a good decision to be made regarding surgical treatment.</p><p>We used the University of Texas classification to evaluate the severity of the lesions. The stage D Grade 3 with 100% risk of amputation was the most present with 29.7%.</p><p>Stage 0 Grade A was found in 4.7%, this result was estimated Djim, F.C. et al. [<xref ref-type="bibr" rid="scirp.112941-ref4">4</xref>] found 10.6%. Stage D Grade 3 with 100% risk of amputation was the most present with 29.7%, while Gu&#232;ye, D.D. et al. [<xref ref-type="bibr" rid="scirp.112941-ref8">8</xref>] found that: grade 1b lesions accounted for 34.0%, followed by 26.4% by grade 2D lesions and 24.5% of grade 3D lesions.</p></sec><sec id="s5"><title>5. Limitations of the Study</title><p>1) Retrospective study whose data collection was based on information provided in medical records, consultation registers, and hospitalization registers, which were often incompletely filled out, sometimes requiring telephone calls from patients.</p><p>2) The high cost of complementary examinations which were at the expense of the patients were often not insured, with the consequence that many patients were excluded for not carrying out examinations which were often useful for the diagnosis and follow-up of their disease.</p><p>3) The limited sampling and the short duration of the study.</p><p>4) The non-use of the chi-square statistical test to compare our results with other studies.</p></sec><sec id="s6"><title>6. Conclusion</title><p>Diabetes in general and the diabetic foot in particular is a real public health problem. The diabetic foot is responsible for formidable and sometimes disabling complications. Its management is multidisciplinary and requires significant financial resources. In Mali, great efforts have been made in recent times to improve care in terms of organization of care and training of diabetic referral doctors.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Doumbia, N., Bakary, D., Ouologuem, N., Sangare, D., Diarra, A.A., Samak&#233;, M., Cisse, S.M., Coulibaly, M., Saliou, M., Dembele, B., Diallo, Y.L., Kone, A., Mariko, M., Traore, B., Konate, M., Traore, D., Sylla, D., Soucko, K.A. and Traore, A. (2021) Diabetic Foot: Epidemiological and Clinical Aspects in the Department of Medicine and Endocrinology of the Hospital of Mali, Mali. Journal of Diabetes Mellitus, 11, 159-170. https://doi.org/10.4236/jdm.2021.114012</p></sec><sec id="s9"><title>Survey Form</title><p>Number: …………………….</p><p>Date: ……………………….</p><p>I. Patient identification</p><p>Q1. Full Name: …………………………………</p><p>Q2. Age: ………………………………………………..</p><p>Q3. Gender: ……………………………………………….</p><p>Q4. Profession/socio-professional activity: …………………………….................</p><p>Q5. Ethnic: …………………………………………</p><p>Q6. Address: ……………………………………………</p><p>Q7. Level of education: ………………………………</p><p>Q8. Origin:</p><p>a. External c. Referred</p><p>b. Transferred d. come by himself</p><p>II. Antecedents</p><p>Q9. Medical: …………………………………………………</p><p>Q10. Surgical: ………………………………………………</p><p>Q11. Gyneco-obstetrics: …………………………………………… ...</p><p>Q12. Family: …………………………………………………</p><p>III. Life style</p><p>Q13. Food habit:</p><p>a. Tobacco c. Tea</p><p>b. Alcohol d. Fat</p><p>e. others</p><p>Q14. Personal hygiene:</p><p>a. Yes b. No</p><p>Q15. Prolonged standing:</p><p>a. Yes b. No</p><p>Q16. Prolonged bed rest:</p><p>a. Yes b. No</p><p>Q17. Frequent walking:</p><p>a. Yes b. No</p><p>Q18. Choice of shoes:</p><p>a. Too tight c. Object in shoes</p><p>b. Wounding</p><p>IV. Socio-economic factors:</p><p>Q19. Economic status:</p><p>a. Bottom c. Raised</p><p>b. Average</p><p>Q20. Access to health services</p><p>a. Yes b. no</p><p>V. Clinical examination:</p><p>Q21. Type of diabetes</p><p>a. Type1</p><p>b. Type2</p><p>c. secondary</p><p>Q22. Mode of wound discovery</p><p>a. Trauma</p><p>b. heat</p><p>vs. intertrigo</p><p>d. pruritus</p><p>e. edema</p><p>Q23. Duration of the wound before arriving at the health center</p><p>………………………………………………………………….</p><p>Q24. The first gesture made in front of the wound</p><p>a. Self-medication</p><p>b. Traditional treatment</p><p>c. Come to the health center</p><p>Q25. Anti-diabetic treatment followed</p><p>a. None c. teenager</p><p>b. Insulin d. diet alone</p><p>Q26. Duration of treatment</p><p>………………………………………………………………………………………</p><p>27. Blood sugar</p><p>a. Balanced b. unbalanced</p><p>Q28. Duration of the wound</p><p>………………………………………………………………………………</p><p>Q29. Wound site</p><p>a. Toes c. front of the foot</p><p>b. Posterior surface of the internal edge foot d. Internal edge</p><p>e. outer edge</p><p>VI. Physical examination</p><p>Q30. Temperature …………………………… c</p><p>Q31. FR …………………………………………… cycle/min</p><p>Q32. FC …………………………………………… beats/min</p><p>Q33. Weight …………………………………….... kg</p><p>Q34. BMI ……………………………………………</p><p>Q35. Type of lesion</p><p>a. Superficial</p><p>b. Deep not gangrenous</p><p>c. Wet gangrene</p><p>d. Dry gangrene</p><p>Q35. Associated lesions</p><p>a. Renal c. Ocular</p><p>b. Cardiac d. neurological</p><p>VII. Additional tests</p><p>Q36. Blood sugar Yes No</p><p>If yes result ……………………………………………………………… ..</p><p>Q37. NFS1-VS Yes No</p><p>If yes result ……………………………………………………………………</p><p>………………………………………………………………………………………</p><p>Q38. Serum creatinine Yes No</p><p>If yes result ……………………………………………………………………</p><p>Q39. Cardiac doppler ultrasound</p><p>Yes No</p><p>If yes result ……………………………………………………………………</p><p>Q40. X-ray of the feet</p><p>Yes No</p><p>If yes result ………………………………………………………………… ...</p><p>Q41. Doppler ultrasound of the lower limbs</p><p>Yes No</p><p>If yes result ……………………………………………………………………</p><p>Q42. The culture of pus</p><p>Yes No</p><p>If yes result …………………………………………………………………</p><p>Q43. Blood culture yes no</p><p>If yes result ………………………………………………………………….</p><p>VIII. Supported</p><p>Q44. Medical treatment</p><p>a. Slow insulin d. Mono antibiotic therapy</p><p>b. Rapid insulin e. Bi antibiotic therapy</p><p>c. Analgesic</p><p>Q45. Surgical treatment</p><p>a. Distal arterial bypass c. Partial amputation</p><p>b. Angioplasty d. Total amputation</p></sec></body><back><ref-list><title>References</title><ref id="scirp.112941-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">International Diabetes Federation (2015) IDF Framework for Action on Sugar. Brussel.</mixed-citation></ref><ref id="scirp.112941-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kamalakannan, D., Baskar, V., Barton, D.M. and Abdu, T.A. (2003) Diabetic Ketoacidosis in Pregnancy. Postgraduate Medical Journal, 79, 454-457. https://doi.org/10.1136/pmj.79.934.454</mixed-citation></ref><ref id="scirp.112941-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Csako, G. (1987) False-Positive Results for Ketone with the Drug Mesna and Other Free-Sulfhydryl Compound. Clinical Chemistry, 33, 289-292 https://doi.org/10.1093/clinchem/33.2.289</mixed-citation></ref><ref id="scirp.112941-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Djim, F.C. (2014) Fréquence et prise en charge des pieds diabétiques dans le service de médecine et d’endocrinologie de l’h&amp;#244;pital du Mali Med. FMOS, Bamako.</mixed-citation></ref><ref id="scirp.112941-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Pierre, K.D. (2013) Pied diabétique dans le service d’endocrinologie—Diabétologie du CHU de Yopougon. février 2013; Yopougon; Colloque SERVIER.</mixed-citation></ref><ref id="scirp.112941-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sani, R., et al. (2010) Le pied diabétique: Aspects épidémiologiques, cliniques et thérapeutiques à l’h&amp;#244;pital national de Niamey A propos de 90 cas. Medecine d’Afrique Noire, 57, 172-176.</mixed-citation></ref><ref id="scirp.112941-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Nghario, L., et al. (2017) Les pieds diabétiques: Aspects épidémiologique, clinique et thérapeutique à propos de 62 cas. Revue de Chirurgie d’Afrique Centrale (RECAC), 2, 9-24.</mixed-citation></ref><ref id="scirp.112941-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Guèye, D.D., et al. (2020) Profil épidémio-clinique et évolutif du pied diabétique au Centre Hospitalier Régional de Saint-Louis. Revue Africaine de Médecine Interne, 7, 14-18.</mixed-citation></ref><ref id="scirp.112941-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sano, D., Tieno, H., Drabo, Y. and Sanou, A. (1999) Prise en charge du pied diabétique: A propos de 42 cas au CHU de Ouagadougou. Médecine d’Afrique Noire, 46, 307-311.</mixed-citation></ref><ref id="scirp.112941-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Djibril, A.M., et al. (2018) Pied diabétique: Aspects épidémiologique, diagnostique, thérapeutique et évolutif à la Clinique Médico-chirurgicale du CHU Sylvanus Olympio de Lomé. The Pan African Medical Journal, 30, Article No. 4. https://doi.org/10.11604/pamj.2018.30.4.14765</mixed-citation></ref><ref id="scirp.112941-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Samaké, D. (2005) Etude épidémio clinique les amputations consécutives aux complications du diabète dans le service de chirurgie orthopédique et traumatologique de l’H&amp;#244;pital Gabriel Toure. Thèse: Med, FMOS, Bamako.</mixed-citation></ref><ref id="scirp.112941-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Traoré, D.Y. (2013) La prévalence de la neuropathie diabétique en commune I du district de Bamako. Thèse: Med. FMOS, Bamako.</mixed-citation></ref><ref id="scirp.112941-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">ékoé, J., Goldenberg, R. and Katz, P. (2018) Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Screening for Diabetes in Adults. Canadian Journal of Diabetes, 42, S16-S19. https://doi.org/10.1016/j.jcjd.2017.10.004</mixed-citation></ref></ref-list></back></article>